Bluejay Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BJDX research report →
About the company
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system.
- CEO
- Indranil Dey
- IPO
- 2021
- Employees
- 7
- HQ
- Acton, MA, US
Price Chart
- Market Cap
- $517.04K
- P/E
- -0.07
- P/S
- 0.00
- P/B
- 0.12
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -144.27%
- ROIC
- -163.49%
- Revenue
- $0 · 0.00%
- Net Income
- $-6,848,483 · 11.26%
- EPS
- $-15.25 · 96.66%
- Op Income
- $-6,952,972
- FCF YoY
- 23.37%
- 52W High
- $16.68
- 52W Low
- $1.03
- 50D MA
- $2.71
- 200D MA
- $4.01
- Beta
- 0.82
- Avg Volume
- 1.39M
Get TickerSpark's AI analysis on BJDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 14, 26 | Wurth Douglas Clark | buy | 12,500 |
| Mar 14, 26 | Dey Indranil | buy | 12,500 |
| Mar 14, 26 | CHASE DONALD R | buy | 12,500 |
| Mar 14, 26 | ZEIDMAN FRED S | buy | 12,500 |
| Mar 14, 26 | Dey Svetlana | buy | 12,500 |
| Dec 13, 23 | Dey Svetlana | buy | 500 |
| Dec 13, 23 | Dey Indranil | buy | 500 |
| Sep 26, 23 | Scally Frances P | other | 0 |
| Mar 24, 23 | Dey Svetlana | buy | 10,000 |
| Mar 28, 23 | Dey Indranil | buy | 2,000 |
Our BJDX coverage
Recent articles, reports, and earnings notes.
No research on BJDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BJDX report →Similar companies
Peers in the same neighborhood.